Occurrence of extended-spectrum beta-lactamases in Enterobacteriaceae isolated from hospitalized patients in Curitiba, southern Brazil

Brazilian Journal of Infectious Diseases

Volumn 10, Issue 6, 2006, Pages 390-395

  Nogueira, Keite da Silva ^a   Higuti, Ilma Hiroko ^a   do Nascimento, Agnaldo José ^a   Terasawa, Larissa Bail ^a   de Oliveira, Simone ^a   Matos, Adriana Pereira ^a,b   de Souza, Helena Aguilar Peres Homem de Mello ^a   Cogo, Laura Lúcia ^a   Dalla Costa, Libera Maria ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b HOSPITAL UNIVERSITÁRIO CAJURU   (Brazil)

Author keywords

Beta lactamases; Enterobacteriaceae; ESBL

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BRAZIL; CONTROLLED STUDY; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ENZYME ANALYSIS; ENZYME SYNTHESIS; ESCHERICHIA COLI; FREQUENCY ANALYSIS; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; SENSITIVITY ANALYSIS; TEACHING HOSPITAL; TERTIARY HEALTH CARE; VALIDATION PROCESS;

EID: 34247130531     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702006000600006     Document Type: Article

References (40)

1. Knothe H., Shah P., Kremery V., et al. Transferable resistance to cefotaxime, cefoxitina, cefamandole e cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315-7.
2. Bradford P.A. Extended-spectrum â-lactamases in the 21st century: caracterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
3. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for â-lactamases and its correlation with molecular structures. Antimicrob Agents Chemother 1995;39:1211-33.
4. Bonnet R. Growing Group of Extended-Spectrum â-lactamases: the CTX-M Enzymes. Antimicrob Agents Chemother 2004;48:1-14.
5. Queenan A.M., Foleno B., Gownley C., et al. Effects of inoculum and â-lactamase activity in AmpC - and extended-spectrum â-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J Clin Microbiol 2004;42:269-75.
6. Gruteke P., Goessens W., Gils J., et al. Patterns of resistance associated with integrons, the extended-spectrum â-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J Clin Microbiol 2003;41:1161-6.
7. Mulvey M.R., Soule G., Boyd D., et al. Characterization of the first extended-spectrum beta-lactamase-producing Salmonella isolate identified in Canada. J Clin Microbiol 2003;41:460-2.
8. Schwaber M.J., Raney P.M., Rasheed L.K., et al. Utility of NCCLS guidelines for identifying extended-spectrum à-lactamases in non- Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae. J Clin Microbiol 2004;42:294-8.
9. Janis E.R. Maintenance by criopreservation. In Janis E.R Maintenace of Microrganisms a Manual of Laboratory Methods. 2.ed. London: Academic Press INC, 1994.
10. Schreckenberber P.C., Janda J.M. Wong J.D., Baron E.J. Algorithims Identification of aerobic Gram-negative bacterias. In Manual of Clinical Microbiology. New York: American Society Microbiology, 2003.
11. Janda J.M., Abbott S.L., Cheung W.K.W., Henson D.F. Biochemical identification of Citrobacteria in the clinical laboratory. J Clin Microbiol 1994;32:1850-4.
12. O'Hara C.M., Brenner F.W., Miller J.M. Classification, identification, and clinical significance of Proteus, Providencia and Morganella. Clin Microbiol Rev 2000;13:534-46.
13. Sanders W.E.J.R., Sanders C.C. Enterobacter spp: Pathogens poised to flourish at the turn of the century. Clin Microbiol Rev 1997; 10:220-41.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard. 7.ed. NCCLS 2003; Document M2-A8. NCCLS. Wayne. PA.
15. Clinical Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Wayne, PA: CLSI 2005.
16. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 5.ed., Document M7-A6. Wayne, PA: NCCLS 2003.
17. Podschun R., Ullmann, A. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. J Clin Microbiol 1998;11:589-603.
18. Mendes C., Hsiung A., Kiffer C., et al. Evaluation of the in vivo Activity of 9 Antimicrobials Against Bacterial Strains Isolated from Patients in Intensive Care Units in Brazil: MYSTIC Antimicrobial Surveillance Program. Braz J Infect Dis 2000;4:236-44.
19. Pagani L., Migliavacca R., Pallecchi L., et al. Emerging extended-spectrum â-lactamases in Proteus mirabilis. J Clin Microbiol 2002;40:1549-52.
20. Champs C., Bonnet R., Sirot D., et al. Clinical relevance of Proteus mirabilis in hospital patients: a two year survey. J Antimicrob Chemoter 2000;45:537-9.
21. Sader H.S., Gales A.C., Pfaller M.A., et al. Pathogen frequency and resistance patterns in brazilian hospitals: summary of results from three years of the SENTRY antimicrobial surveillance program. Braz J Infect Dis 2001;5:200-14.
22. Tenover F.C., Mohammed M.J., Gorton T.S., Dembek Z.F. Detection and reporting of organisms producing extended-spectrum â-lactamases: survey of laboratories in Connecticut. J Clin Microbiol 1999; 37:4065-70.
23. Varela C., Oliver A., Coque T.M., et al. Prevalence of extended-spectrum â-lactamases in group-1 â-lactamases-producing isolates. Clin Microbiol Infect 2001;7:278-82.
24. Thomson K.S. Controversies about extended-spectrum and AmpC beta-lactamases. Em Infect Dis 2001;7:333-6.
25. Yan J.J., Ko W., Wu H., et al. Complexity of Klebsiella pneumoniae Isolates Resistant to Both Cephamycins and Extended-Spectrum Cephalosporins at a Teaching Hospital in Taiwan. J Clin Microbiol 2004;42:5337-40.
26. Coudron P.E., Hanson N.D., Climo M.W. Occurrence of extended-spectrum â-lactamase in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediate FOX-5 and ACT-1 AmpC â-lactamases. J Clin Microbiol 2003;41:772-7.
27. Livermore D.M. â-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 2001;8:557-84.
28. Bonnet R., Dutour C., Sampaio J.L.M., et al. Novel Cefotaximase (CTX-M-16) with Increased Catalytic Efficiency Due to Substitution Asp-240? Gly. Antimicrob Agents Chemother 2001;45:2269-75.
29. Livermore D.M. â-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-84.
30. Bonnet R., Sampaio J.L.M., Labia R., et al. A novel CTX-M â-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob Agents Chemother 2000;44:1936-42.
31. Livermore D.M., Brown D.F.J. Detection of â-lactamase-mediated resistance. J Antimicrobial Chemoter 2001;48:59-64.
32. M 'Zali F.H., Chanawong A., Kerr K.G., et al. Detection of extended-spectrum â-lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disk and the E-test ESBL, J Antimicrobial Chemoter 2000;45:881-5.
33. Kholer J., Dorso K.L., Young K., et al. In vitro Activies of the Potent, Broad Spectrum Carbapenem MK-0826 (L-749,345) against Broad-Spectrum â-lactamases and Extended-spectrum â-lactamase-producing Klebsiella pneumoniae and Escherichia coli Clinical Isolates. Antimicrob Agents Chemother 1999;43:1170-6.
34. Livermore D.M., Sefton A.M., Scott G.M. Properties e Potential of Ertapenem. J Antimicrobial Chemoter 2003;52:331-44.
35. Livermore D.M., Oakton K.J., Carter M.W., Warner M. Activity of Ertapenem (MK-0826) versus Enterobacteriaceae with Potent â-lactamases. Antimicrob Agents Chemother 2001;45:2831-7.
36. Fuchs P.C., Barry A.L., Brown S.D. In vitro Activities of Ertapenem (MK-0826) agains Clinical Bacterial Isolates from 11 North American Medical Centers. Antimicrob Agents Chemother 2001; 45:1915-8.
37. Patterson J.E. Antibiotic utilization: is there an effect on antimicrobial resistance? Chest 2001;119:426-30.
38. Shukia I., Tiwari R., Agraval M. Prevalence of extended spectrum â-lactamase producing Klebsiella pneumoniae in a tertiary care hospital. Indian J of Med Microbiol 2004;22:87-91.
39. Tavares W. Aminoglicosideos In: Tavares W. Manual de antibiótico e quimioterápicos antiinfecciosos. São Paulo: Atheneu, 2001.
40. Essack S.Y. Laboratory detection of extended-spectrum â-lactamases (ESBLs) The need for a realiable, reproducible method. Diagn Microbial Infec Dis, 2000;37:2000.